No Data
Star Lake Bioscience (600866.SH): Yipin Group and its concerted actions, including Tie Xiaorong, have cumulatively reduced their shareholding by 1.68%.
On November 29, Gelonghui reported that star lake bioscience (600866.SH) announced it received a "Notice of Bulk Trade Shareholding Reduction Results" issued by Yipin Group and its concerted actor Tie Xiaorong. As of November 28, 2024, the shareholding reduction period for this plan has expired, and Yipin Group and its concerted actor Tie Xiaorong have collectively reduced their holdings in the company by 27,906,730 shares through bulk trading, accounting for 1.68% of the company's total share capital. As of the date of this announcement, Yipin Group and its concerted actor Tie Xiaorong hold a total of 282,914,780 shares in the company, accounting for 17% of the company's total share capital.
Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Five-year Earnings Growth Trails the 10% YoY Shareholder Returns
xingfa alum subsidiary plans to sell part of the equity of Guangdong Guangxin Innovation Research Institute
Xingfa Alum (00098) announced on November 6, 2024, that Guangdong Xingfa (an indirect wholly-owned subsidiary of the company), FSPG Hi-Tech, and Star Lake Bioscience have entered into an equity transfer agreement with Guangxin Holdings. According to the equity transfer agreement, Guangdong Xingfa, FSPG Hi-Tech, and Star Lake Bioscience each agree to sell and transfer 2.80% of the equity of Guangdong Guangxin Innovation Research Institute Co., Ltd., while Guangxin Holdings agrees to purchase and accept a total of 8.40% of the equity of the target company. The total consideration for the sale is approximately RMB 33.5594 million, with Guangdong Xingfa's sale price around RMB 111 million.
Is Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Using Too Much Debt?
Xinghu Technology: Third Quarter Report 2024
Third Quarter Report 2024
